Viewing Study NCT05665192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-01-25 @ 1:06 AM
Study NCT ID: NCT05665192
Status: COMPLETED
Last Update Posted: 2025-04-08
First Post: 2022-12-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib
Sponsor: Bristol-Myers Squibb
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelofibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Primary Myelofibrosis View
None Thrombocythemia Myelofibrosis View
None Fedratinib View
None Ruxolitinib View